Opioids Stocks List

Recent Signals

Date Stock Signal Type
2021-04-16 AQST Narrow Range Bar Range Contraction
2021-04-16 BDSI Stochastic Buy Signal Bullish
2021-04-16 PMD 50 DMA Resistance Bearish
2021-04-16 PMD Stochastic Sell Signal Bearish
2021-04-16 PMD 180 Bearish Setup Bearish Swing Setup
2021-04-16 PRFX New 52 Week Low Weakness
2021-04-16 PRFX New 52 Week Closing Low Bearish
2021-04-16 PRFX Lower Bollinger Band Walk Weakness
2021-04-16 TTNP Stochastic Buy Signal Bullish
2021-04-16 TTNP New 52 Week Low Weakness
2021-04-16 TTNP Doji - Bullish? Reversal
2021-04-16 TTNP Lizard Bullish Bullish Day Trade Setup
2021-04-16 TTNP Lower Bollinger Band Walk Weakness
2021-04-16 VRPX New 52 Week Low Weakness
2021-04-16 VRPX New 52 Week Closing Low Bearish

Recent News for Opioids Stocks

Date Stock Title
Apr 18 AQST AQST INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AQST
Apr 16 AQST LOSS ALERT: ROSEN, NATIONAL INVESTOR COUSNEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - AQST
Apr 16 AQST ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action - AQST
Apr 16 AQST MGI, AQST & VLDR Looming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
Apr 15 COLL Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and Provide Corporate Update
Apr 14 AQST MGI, AQST & VLDR Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
Apr 14 ENDP Endo's Qwo shows 'meaningful improvement' in late-sage cellulite study in women
Apr 13 ENDP Endo to Announce First Quarter 2021 Financial Results
Apr 13 ENDP Endo Announces Publication of Phase 3 Qwo® (collagenase clostridium histolyticum-aaes) Data in Peer-Reviewed Dermatologic Surgery
Apr 12 AQST Rosen, Leading Trial Attorneys, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST
Apr 12 AQST FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Apr 12 ENDP ADVANZ PHARMA and Endo Announce Partnership for Paladin Labs to Commercialize Xydalba® (dalbavancin hydrochloride) in Canada
Apr 12 VRPX 51 Biggest Movers From Friday

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, suppressing cough, suppressing opioid induced constipation, as well as for executions in the United States. Extremely potent opioids such as carfentanil are only approved for veterinary use. Opioids are also frequently used non-medically for their euphoric effects or to prevent withdrawal.

Side effects of opioids may include itchiness, sedation, nausea, respiratory depression, constipation, and euphoria. Tolerance and dependence will develop with continuous use, requiring increasing doses and leading to a withdrawal syndrome upon abrupt discontinuation. The euphoria attracts recreational use and frequent, escalating recreational use of opioids typically results in addiction. An overdose or concurrent use with other depressant drugs commonly results in death from respiratory depression.Opioids act by binding to opioid receptors, which are found principally in the central and peripheral nervous system and the gastrointestinal tract. These receptors mediate both the psychoactive and the somatic effects of opioids. Opioid drugs include partial agonists, like the anti-diarrhea drug loperamide and antagonists like naloxegol for opioid-induced constipation, which do not cross the blood-brain barrier, but can displace other opioids from binding to those receptors.
Because opioids are addictive and may result in fatal overdose, most are controlled substances. In 2013, between 28 and 38 million people used opioids illicitly (0.6% to 0.8% of the global population between the ages of 15 and 65). In 2011, an estimated 4 million people in the United States used opioids recreationally or were dependent on them. As of 2015, increased rates of recreational use and addiction are attributed to over-prescription of opioid medications and inexpensive illicit heroin. Conversely, fears about over-prescribing, exaggerated side effects and addiction from opioids are similarly blamed for under-treatment of pain.

More about Opioids
Browse All Tags